EMEA consults on improving its service
The European Medicines Agency (EMEA) has launched a two-month consultation procedure on proposed improvements to how it provides scientific advice on the research and development of new medicines. The deadline for comments is November 22.
The European Medicines Agency (EMEA) has launched a two-month consultation procedure on proposed improvements to how it provides scientific advice on the research and development of new medicines. The deadline for comments is November 22.
The agency has also published advice on the impact of new European Union pharmaceutical legislation on its centralised marketing authorisation procedures, as well as revised guidance on allergen products.
Visit
http://www.emea.eu.int/pdfs/human/sciadvice/31176205en.pdf http://www.emea.eu.int/pdfs/human/euleg/24328005en.pdf http://www.emea.eu.int/pdfs/human/bwp/22947205en.pdf